Skip to main content
Caplight Logo









Nemesis Bioscience

Nemesis Bioscience

Private
CambridgeHealthcare & Life Scienceshttps://nemesisbio.com

Company Overview

Nemesis Bioscience was a biopharmaceutical company that developed DNA therapeutics designed to reverse microbial resistance to antibiotics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antimicrobial resistanceAMRDNA therapeuticsantibiotic resistancesuperbugsbacterial pathogensgene therapyprobiotic platformhospital-acquired infectionsbiotechnologydrug discoverycybergeneticsendonucleases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nemesis Bioscience Comparables

Compare Nemesis Bioscience with similar companies based on industry and business-model similarity.

Nemesis Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eligo Bioscience
82%
Locus Biosciences
76%
SNIPR Biome
75%
View all Comparables

Nemesis Bioscience Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Nemesis Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nemesis Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nemesis Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?